Article
Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children.
Pediatric obesity - 1 Apr 2014
Ooi S Q, Chan R M E, Poh L K S, Loke K Y, Heng C K, Chan Y H, Gan S U, Lee K O, Lee Y S
Abstract excerpt
BACKGROUND: Visfatin is an adipokine, associated with obesity and possibly glucose regulation. OBJECTIVE: The aim of this study was to examine the association of visfatin and its genetic variants with adiposity, cardiometabolic risk factors and obesity-related morbidities in obese children. METHODS: Anthropometric measurements, dual energy X-ray absorptiometry scan, fasting blood samples and oral glucose...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
